OTCMKTS:CNBX - Cannabics Pharmaceuticals Stock Price, News, & Analysis

-0.02 (-6.80 %)
(As of 07/24/2019 01:32 AM ET)
Today's Range
Now: $0.2894
50-Day Range
MA: $0.30
52-Week Range
Now: $0.2894
Volume120,692 shs
Average Volume146,932 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Cannabics Pharmaceuticals Inc., an early stage biotechnology company, engages in the development and licensing of cannabinoid-based treatments and therapies. The company focuses on developing and marketing therapies and biotechnological tools for the relief from various ailments that respond to active ingredients sourced from the cannabis plant. It offers Cannabics SR, a medical cannabis capsules to treat cancer related cachexia/anorexia syndrome in advanced cancer patients. The company also focuses on the commercialization of a diagnostic test based on liquid biopsies of patients suffering from epithelial cancers; and development of diagnostics that monitor cancer progression and cannabinoid cancer sensitivity tests for the treatment of cancer with cannabinoid medicine. Cannabics Pharmaceuticals Inc. has a collaboration with SIMFO GmbH for circulating tumor cell drug sensitivity tests. The company was formerly known as American Mining Corporation and changed its name to Cannabics Pharmaceuticals Inc. in May 2014. Cannabics Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. Cannabics Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolOTCMKTS:CNBX



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive CNBX News and Ratings via Email

Sign-up to receive the latest news and ratings for CNBX and its competitors with MarketBeat's FREE daily newsletter.

Cannabics Pharmaceuticals (OTCMKTS:CNBX) Frequently Asked Questions

What is Cannabics Pharmaceuticals' stock symbol?

Cannabics Pharmaceuticals trades on the OTCMKTS under the ticker symbol "CNBX."

Has Cannabics Pharmaceuticals been receiving favorable news coverage?

Media coverage about CNBX stock has been trending very negative recently, InfoTrie reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cannabics Pharmaceuticals earned a coverage optimism score of -3.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Cannabics Pharmaceuticals.

Who are some of Cannabics Pharmaceuticals' key competitors?

What other stocks do shareholders of Cannabics Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabics Pharmaceuticals investors own include OrganiGram (OGI), Canopy Growth (CGC), Aurora Cannabis (ACBFF), Cannabis Science (CBIS), Cronos Group (CRON), Medical Marijuana (MJNA), Energous (WATT), Micron Technology (MU), Aphria (APHQF) and mCig (MCIG).

Who are Cannabics Pharmaceuticals' key executives?

Cannabics Pharmaceuticals' management team includes the folowing people:
  • Mr. Eyal Barad, Co-Founder, CEO & Director (Age 54)
  • Dr. Eyal Ballan Ph.D., Co-founder, CTO & Director (Age 43)
  • Mr. Uri Ben-Or CPA, M.B.A., CPA, MBA, CFO & Principal Accounting Officer (Age 49)
  • Mr. David E. Price, Sec. & Corp. Counsel (Age 54)
  • Mr. Yasha Borstein, Chief Data Officer (Age 56)

How do I buy shares of Cannabics Pharmaceuticals?

Shares of CNBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cannabics Pharmaceuticals' stock price today?

One share of CNBX stock can currently be purchased for approximately $0.2894.

What is Cannabics Pharmaceuticals' official website?

The official website for Cannabics Pharmaceuticals is http://www.cannabics.com/.

How can I contact Cannabics Pharmaceuticals?

Cannabics Pharmaceuticals' mailing address is #3 Bethesda Metro Center, Suite 700, BETHESDA, MD 20814, United States. The company can be reached via phone at +1-877-4242429.

MarketBeat Community Rating for Cannabics Pharmaceuticals (OTCMKTS CNBX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Cannabics Pharmaceuticals and other stocks. Vote "Outperform" if you believe CNBX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNBX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/24/2019 by MarketBeat.com Staff

Featured Article: What causes a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel